Sheba Hospital in Israel’s clinical trial found people who received a fourth dose of a COVID-19 vaccine showed increases in antibodies “slightly higher” than following the third vaccine last year. But it said the increased antibodies did not prevent the spread of omicron. MAYA ALLERUZZO/AP
Josef Federman ASSOCIATED PRESS JERUSALEM – An Israeli hospital on Monday said preliminary research indicates a fourth dose of the coronavirus vaccine provides only limited…
